United States · FDA National Drug Code directory
Bupivacaine HCl
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70594-119_6776a37a-5872-4c0c-b039-6d93e3604e7c
- Product NDC
- 70594-119
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Bupivacaine Hydrochloride
- Labeler
- Xellia Pharmaceuticals USA LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230801
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPIVACAINE HYDROCHLORIDE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 50 mL in 1 VIAL, MULTI-DOSE (70594-119-01) · 70594-119-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →